Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW.

Arthritis Rheum. 2000 Sep;43(9):2025-33.

2.

Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.

Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Tervaert JW.

J Immunol Methods. 2003 Mar 1;274(1-2):27-35.

PMID:
12609530
4.

Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.

Teixeira L, Mahr A, Jaureguy F, Noël LH, Nunes H, Lefort A, Barry S, Deny P, Guillevin L.

Rheumatology (Oxford). 2005 Feb;44(2):247-50. Epub 2004 Nov 16.

PMID:
15546964
5.

Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.

Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL.

Rheumatology (Oxford). 2004 Feb;43(2):174-80. Epub 2003 Oct 29.

PMID:
14585921
6.

Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.

Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AE, Kallenberg CG, Goldschmeding R.

Clin Exp Immunol. 1993 Sep;93(3):405-10.

7.

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.

Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U; WGET Research Group.

Ann Intern Med. 2007 Nov 6;147(9):611-9.

PMID:
17975183
9.
10.

Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis.

Kyndt X, Reumaux D, Bridoux F, Tribout B, Bataille P, Hachulla E, Hatron PY, Duthilleul P, Vanhille P.

Am J Med. 1999 May;106(5):527-33.

PMID:
10335724
11.

IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.

Liu LJ, Chen M, Yu F, Zhao MH, Wang HY.

Nephrology (Carlton). 2008 Oct;13(7):629-35. doi: 10.1111/j.1440-1797.2008.00976.x. Epub 2008 Sep 3.

PMID:
18775059
13.
14.
15.

Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.

Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, Tervaert JW.

Ann N Y Acad Sci. 2007 Aug;1109:454-63.

PMID:
17785334
16.

Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.

Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, Kallenberg CG.

Br J Rheumatol. 1996 Jul;35(7):625-31.

PMID:
8670594
17.
18.

Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.

Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, Zhao MH, Wang HY.

Nephrol Dial Transplant. 2007 Jan;22(1):139-45. Epub 2006 Sep 15.

PMID:
16980322
19.

[Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].

Zhang X, Jiang M, Chui J, Wang H, Ma J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1997 Aug;19(4):284-7. Chinese.

PMID:
10453568
20.

Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.

Vassilopoulos D, Niles JL, Villa-Forte A, Arroliga AC, Sullivan EJ, Merkel PA, Hoffman GS.

Arthritis Rheum. 2003 Apr 15;49(2):151-5.

Supplemental Content

Support Center